VIVANI MEDICAL INC (VANI) Stock Fundamental Analysis

NASDAQ:VANI • US92854B1098

1.3 USD
0 (0%)
Last: Feb 20, 2026, 08:09 PM
Fundamental Rating

1

VANI gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 185 industry peers in the Health Care Equipment & Supplies industry. While VANI seems to be doing ok healthwise, there are quite some concerns on its profitability. VANI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • VANI had negative earnings in the past year.
  • VANI had a negative operating cash flow in the past year.
  • In the past 5 years VANI always reported negative net income.
  • VANI had a negative operating cash flow in each of the past 5 years.
VANI Yearly Net Income VS EBIT VS OCF VS FCFVANI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

  • With a Return On Assets value of -103.91%, VANI is not doing good in the industry: 79.46% of the companies in the same industry are doing better.
  • VANI has a Return On Equity of -1988.24%. This is amonst the worse of the industry: VANI underperforms 85.95% of its industry peers.
Industry RankSector Rank
ROA -103.91%
ROE -1988.24%
ROIC N/A
ROA(3y)-46.43%
ROA(5y)-97.1%
ROE(3y)-95.73%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VANI Yearly ROA, ROE, ROICVANI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K -1K 2K

1.3 Margins

  • VANI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VANI Yearly Profit, Operating, Gross MarginsVANI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

4

2. Health

2.1 Basic Checks

  • Compared to 1 year ago, VANI has more shares outstanding
  • VANI has more shares outstanding than it did 5 years ago.
  • VANI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
VANI Yearly Shares OutstandingVANI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
VANI Yearly Total Debt VS Total AssetsVANI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • VANI has an Altman-Z score of -8.97. This is a bad value and indicates that VANI is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -8.97, VANI is not doing good in the industry: 75.14% of the companies in the same industry are doing better.
  • VANI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -8.97
ROIC/WACCN/A
WACCN/A
VANI Yearly LT Debt VS Equity VS FCFVANI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

  • VANI has a Current Ratio of 0.61. This is a bad value and indicates that VANI is not financially healthy enough and could expect problems in meeting its short term obligations.
  • VANI's Current ratio of 0.61 is on the low side compared to the rest of the industry. VANI is outperformed by 91.89% of its industry peers.
  • VANI has a Quick Ratio of 0.61. This is a bad value and indicates that VANI is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.61, VANI is doing worse than 89.19% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.61
Quick Ratio 0.61
VANI Yearly Current Assets VS Current LiabilitesVANI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

0

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 0.00% over the past year.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, VANI will show a very negative growth in Earnings Per Share. The EPS will decrease by -19.85% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y4.95%
EPS Next 2Y9.02%
EPS Next 3Y-3.62%
EPS Next 5Y-19.85%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
VANI Yearly Revenue VS EstimatesVANI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2029 2030 2031 2032 2033 100M 200M 300M 400M
VANI Yearly EPS VS EstimatesVANI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 -5 -10 -15

0

4. Valuation

4.1 Price/Earnings Ratio

  • VANI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for VANI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VANI Price Earnings VS Forward Price EarningsVANI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VANI Per share dataVANI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.1 -0.2 -0.3 -0.4

4.3 Compensation for Growth

  • VANI's earnings are expected to decrease with -3.62% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y9.02%
EPS Next 3Y-3.62%

0

5. Dividend

5.1 Amount

  • No dividends for VANI!.
Industry RankSector Rank
Dividend Yield 0%

VIVANI MEDICAL INC

NASDAQ:VANI (2/20/2026, 8:09:10 PM)

1.3

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-13
Earnings (Next)03-30
Inst Owners5.37%
Inst Owner Change31.96%
Ins Owners45.58%
Ins Owner Change0.21%
Market Cap105.57M
Revenue(TTM)N/A
Net Income(TTM)-26.03M
Analysts82.22
Price Target5.1 (292.31%)
Short Float %0.77%
Short Ratio1.21
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-7.84%
Min EPS beat(2)-17.65%
Max EPS beat(2)1.96%
EPS beat(4)2
Avg EPS beat(4)-4.11%
Min EPS beat(4)-17.65%
Max EPS beat(4)1.96%
EPS beat(8)6
Avg EPS beat(8)3.25%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)4.76%
EPS NY rev (1m)2.38%
EPS NY rev (3m)5.75%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 80.65
P/tB 80.65
EV/EBITDA N/A
EPS(TTM)-0.45
EYN/A
EPS(NY)-0.36
Fwd EYN/A
FCF(TTM)-0.3
FCFYN/A
OCF(TTM)-0.29
OCFYN/A
SpS0
BVpS0.02
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -103.91%
ROE -1988.24%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-46.43%
ROA(5y)-97.1%
ROE(3y)-95.73%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 300.25%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.61
Quick Ratio 0.61
Altman-Z -8.97
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)158.98%
Cap/Depr(5y)139.49%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y4.95%
EPS Next 2Y9.02%
EPS Next 3Y-3.62%
EPS Next 5Y-19.85%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-11.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year5.57%
EBIT Next 3Y-15.98%
EBIT Next 5Y-39.03%
FCF growth 1Y3.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y7.93%
OCF growth 3YN/A
OCF growth 5YN/A

VIVANI MEDICAL INC / VANI FAQ

Can you provide the ChartMill fundamental rating for VIVANI MEDICAL INC?

ChartMill assigns a fundamental rating of 1 / 10 to VANI.


What is the valuation status for VANI stock?

ChartMill assigns a valuation rating of 0 / 10 to VIVANI MEDICAL INC (VANI). This can be considered as Overvalued.


Can you provide the profitability details for VIVANI MEDICAL INC?

VIVANI MEDICAL INC (VANI) has a profitability rating of 0 / 10.


Can you provide the financial health for VANI stock?

The financial health rating of VIVANI MEDICAL INC (VANI) is 4 / 10.